Robin L. Smith

Robin L. Smith has filed trades across 8 companies (mainly through SEC (Form 4)), most often in Lisata Therapeutics, Inc., Emmaus Life Sciences, Inc. and Viridian Therapeutics, Inc.\DE. We count 78 filings; the first trade dates from 2 June 2006 and the latest from 14 June 2023.

On the market, this insider has only ever bought: 11 purchases, €40.8M in total. The totals exclude 3 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 57 share grants and 6 option exercises.

In size, the median ticket on the buying side is €26k.

Most recently, on 16 June 2023, the filings show a share grant in Celularity Inc. The most recent open-market purchase was published on 21 May 2020, 2,347 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.